VPH2010 - First VPH Conference: Call for Papers

30 September - 1 October 2010, Brussels, Belgium.
The Virtual Physiological Human Network of Excellence (VPH NoE) will hold the first of a series of VPH Conferences (VPH2010) supported by the European Commission ICT for Health / DG Information Society and Media.

The Virtual Physiological Human Network of Excellence is an umbrella project representing the Virtual Physiological Human Initiative set up by the European Commission with a budget of ~ 350 million Euros for the Framework 7 Program. The VPH NoE is also responsible for producing a 'VPH Vision and Strategy Document' to inform the next calls for the VPH field for FP7, FP8 and for European large infrastructural actions.

The meeting on 30th September - 1st October will be dedicated to the VPH Initiative, bringing together key representatives from VPH groups, Industry and Clinics. The first meeting is designed to be a relatively small meeting up to a maximum of 200 participants with high profile key speakers and will contain the very best of VPH research. Parallel sessions will be held on both days with proposed topics in four main themes; Organ Systems, Modelling Scales, Research Methodology, Application Domains and Data Access and Information Assurance.

Submissions for posters or for oral presentations are welcome. Both kinds of submissions will be subject to the same reviewing process. Contributors are asked to submit abstracts rather than full papers. Submitted abstracts will be selected for inclusion in VPH 2010 by the VPH 2010 Programme Committee for:

  • Inclusion as an oral presentation and Invitation to submit a full paper for possible inclusion in the Interface Focus Issue
  • Inclusion as an oral presentation and/or
  • Inclusion as a poster or
  • Not suitable for inclusion

Talks and posters will appear in electronic format on the conference web pages via the VPH NoE website.

The submission should be no more than 2 A4 pages of text (1800 words) or up to three pages if it includes diagrams, tables and references, with the extra space devoted to these and any captions. Font size should be no smaller than 10 pt Times New Roman with 2.5cm margins. All pages should be numbered and diagrams and tables should be positioned in their proper place in relation to the text, ensuring that the total contribution does not exceed 3 pages. Authors invited to prepare full manuscripts for submission to Interface Focus will also need to adhere to a further schedule for submission and review; final copy will be required by 15th February 2011.

Contributions are invited in, but not limited to, the following areas and topics:

  • Organ Systems
  • Neuromusculoskeletal
  • Cardiovascular
  • Lymphatic and immunological
  • Dermatological
  • Respiratory
  • Endocrine-metabolic
  • Modelling Scales
  • Population-organism modelling
  • Organism-organ modelling
  • Organ-tissue modelling
  • Tissue-cell modelling
  • Cell-molecule modelling
  • Research Methodology
  • Data management
  • Numerical methods and modelling tools
  • Experimental methods for models validation
  • Probabilistic and adaptive methods
  • ICT for integrative modelling
  • Multiscale visualisation and data processing
  • Application Domains
  • Systems physiology research
  • Systems Biology research
  • Screening, monitoring and diagnosis
  • Pharmacology and drug development
  • Medical devices design and testing
  • Model assisted planning and treatment
  • Mechanisms and models of disease
  • Data Access & Information Assurance
  • Ethics/Data privacy and security
  • Intellectual property rights
  • Accessing and sharing of medical data: technical, personal, legal and policy perspectives

Key Dates:

  • Early Bird Registration of Euro 280 by 31st July!
  • Deadline for abstract submission: 1st May 2010
  • Authors Notifications: 30th June 2010

For further information and registration, please visit:
http://www.vph-noe.eu/vph2010

Most Popular Now

First Virtual DMEA to Open with a Wide R…

16 - 18 June 2020, Berlin, Germany. Under the heading 'DMEA sparks' and taking place for the first time, this year's DMEA is an entirely virtual event. From 16 to 18...

Philips Launches HealthSuite Clinical Tr…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced Clinical Trial Accelerator on Philips HealthSuite. This new tailored set of capabilities allows life science organizations to...

New AI Diagnostic can Predict COVID-19 w…

Researchers at King's College London, Massachusetts General Hospital and health science company ZOE have developed an artificial intelligence diagnostic that can predict whether someone is likely to have COVID-19 based...

Biomax Provides AI-Based Semantic Search…

The bioinformatics company Biomax, headquartered in Planegg, Germany, makesitssemantic search platform AILANI available free of charge to research institutes around the world in order to support the rapid and successful...

COVID-19 and Health Tech: Building on th…

Highland Marketing's advisory board met to discuss the health tech response to the coronavirus outbreak. In many areas, this has been hugely impressive: but there are gaps, and there will...

InsurTech Hub Munich and dmac/Digital He…

InsurTech Hub Munich (ITHM) and dmac - Medical Valley Digital Health Application Center part of the Digital Health Hub Nuremberg/Erlangen announce a new cross-industry accelerator for the second half of...

Viveo Health Offers Free Telemedicine So…

Viveo Health, a global e-Health innovator, is making its 'Virtual Office for Doctors' platform free of charge to doctors and other medical professionals worldwide in light of the surge in...

The Dedalus Group, Participated by Ardia…

The Dedalus Group, a leading European company, and one of the worldwide main ones, active in clinical healthcare information systems to support clinical professionals and organizations in order to improve...

Supercomputer Simulations Present Potent…

Several drugs approved for treating hepatitis C viral infection were identified as potential candidates against COVID-19, a new disease caused by the SARS-CoV-2 coronavirus. This is the result of research...

The COVID-19 pandemic reveals the potent…

Two new articles provide insights on the use of telehealth or virtual care in the age of COVID-19 and beyond, pointing to its value to not only prevent contagious diseases...

WiFi SPARK Works with Visionable to Conn…

Seven NHS Trusts are using technology developed by WiFi SPARK in response to an urgent request from leading NHS Trusts to find a way to connect hospital patients with their...

Digital Contact Tracing for COVID-19: An…

An article in CMAJ (Canadian Medical Association Journal) analyzes the strengths and limitations of digital contact tracing for people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to help...